ID

23891

Descrizione

Study part: Adverse Events- Post- Vaccination Observation Booster Dose. A phase 2 study to assess safety, reactogenicity and immunogenicity of a booster dose of an investigational vaccination regimen and GSK Biologicals Hib-MenC vaccine (co-administered with Infanrix penta) compared to a booster dose of Menjugate (co-administered with Infanrix hexa).Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Study ID: 100381, Clinical Study ID: 100381

Keywords

  1. 16/07/17 16/07/17 -
Titolare del copyright

GlaxoSmithKline

Caricato su

16 luglio 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Adverse Events- Post- Vaccination Observation Booster Dose Hib-MenCY-TT-004 BST 003 Neisseria Meningitidis-Haemophilus influenzae type b Vaccine 100381

Adverse Events- Post- Vaccination Observation Booster Dose

ADVERSE EVENTS – POST–VACCINATION OBSERVATION
Descrizione

ADVERSE EVENTS – POST–VACCINATION OBSERVATION

Alias
UMLS CUI-1
C0877248
Subject number
Descrizione

Subject number

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
Descrizione

Adverse Events

Tipo di dati

text

Alias
UMLS CUI [1]
C0877248

Similar models

Adverse Events- Post- Vaccination Observation Booster Dose

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
ADVERSE EVENTS – POST–VACCINATION OBSERVATION
C0877248 (UMLS CUI-1)
Subject number
Item
Subject number
integer
C2348585 (UMLS CUI [1])
Item
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
text
C0877248 (UMLS CUI [1])
Code List
Has the subject experienced any serious or non-serious unsolicited adverse events within one month (minimum 30 days) post-vaccination?
CL Item
Information not retrievable [U (Information not retrievable [U)
CL Item
No Vaccine administered [NA (No Vaccine administered [NA)
CL Item
No [N (No [N)
CL Item
Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y (Yes, fill in the Non-Serious Adverse Event pages or Serious Adverse Event form [Y)

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial